ZNF343 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.701000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.897000E-01
Normal-vs-Stage2
4.784800E-01
Normal-vs-Stage3
7.857700E-02
Normal-vs-Stage4
9.380800E-01
Stage1-vs-Stage2
3.238400E-01
Stage1-vs-Stage3
1.376250E-02
Stage1-vs-Stage4
9.000800E-01
Stage2-vs-Stage3
7.041800E-02
Stage2-vs-Stage4
3.473000E-01
Stage3-vs-Stage4
1.066380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.953200E-01
Normal-vs-AfricanAmerican
5.281000E-01
Normal-vs-Asian
1.719800E-01
Caucasian-vs-AfricanAmerican
8.694400E-01
Caucasian-vs-Asian
2.635600E-01
AfricanAmerican-vs-Asian
5.484600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.795000E-01
Normal-vs-Female
4.568800E-01
Male-vs-Female
8.131400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.580600E-01
Normal-vs-Age(41-60Yrs)
7.034200E-01
Normal-vs-Age(61-80Yrs)
4.007000E-01
Normal-vs-Age(81-100Yrs)
3.298400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.977800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.156400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.336400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.443600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.524040E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.482600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.350600E-01
Normal-vs-Daily Drinker
2.377200E-01
Normal-vs-Weekly Drinker
9.094800E-01
Normal-vs-Occasional Drinker
3.078000E-01
Normal-vs-Social Drinker
5.975200E-01
Non Drinker-vs-Daily Drinker
6.708400E-01
Non Drinker-vs-Weekly Drinker
1.392360E-01
Non Drinker-vs-Occasional Drinker
3.064600E-01
Non Drinker-vs-Social Drinker
2.301400E-01
Daily Drinker-vs-Weekly Drinker
8.068400E-02
Daily Drinker-vs-Occasional Drinker
1.532450E-01
Daily Drinker-vs-Social Drinker
1.119640E-01
Weekly Drinker-vs-Occasional Drinker
3.969200E-01
Weekly Drinker-vs-Social Drinker
6.479200E-01
Occasional Drinker-vs-Social Drinker
5.674400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.245400E-01
Normal-vs-Grade 2
8.629600E-01
Normal-vs-Grade 3
8.624200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.654600E-01
Grade 1-vs-Grade 3
3.242400E-01
Grade 1-vs-Grade 4
9.245400E-01
Grade 2-vs-Grade 3
9.882200E-01
Grade 2-vs-Grade 4
8.629600E-01
Grade 3-vs-Grade 4
8.624200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.845800E-01
Normal-vs-NonDiabetic
4.588400E-01
Diabetic-vs-NonDiabetic
3.115400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.428200E-01
Normal-vs-NoPancreatitis
3.985000E-01
Pancreatitis-vs-NoPancreatitis
8.241800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.037000E-01
Normal-vs-N1
5.173200E-01
N0-vs-N1
6.804000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.992600E-01
Normal-vs-TP53-NonMutant
5.452600E-01
TP53-Mutant-vs-TP53-NonMutant
9.896200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
